Financials

  • Market Capitalization 153.7 M
  • Employee 29
  • Founded 2015
  • CEO N/A
  • Website nrxpharma.com
  • Headquarter Delaware, United States
  • FIGI BBG00JCWDN63
  • Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-2.03
ratio cours/chiffre d'affaires
47.35

Related tickers

#NomPrix24h %7 jours %1M %1 an %Cap Boursière7 Derniers Jours
3736
OTLK
Outlook Therapeutics, Inc. - Common Stock
0.64 USD0.00%-3.03%-28.09%+55.15%155.81 M USD
3739
TNYA
Tenaya Therapeutics, Inc. - Common Stock
0.69 USD-1.43%-1.43%-8.00%-40.00%154.72 M USD
3744
INDP
Indaptus Therapeutics, Inc. - Common Stock
1.15 USD-0.86%-10.16%-34.66%-39.47%153.23 M USD
3749
LENZ
LENZ Therapeutics, Inc. - Common Stock
4.84 USD+0.62%+2.54%-16.70%-85.11%152.07 M USD

Nouvelles